Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Revvity Inc (RVTY) vs Vanguard Global ex-US Real Estate Index Fd ETF (VNQI) Price & Performance

Revvity IncTrade
Vanguard Global ex-US Real Estate Index Fd ETFTrade

Price performance (Past 24H)

Key statistics

Revvity Inc vs Vanguard Global ex-US Real Estate Index Fd ETF — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Vanguard Global ex-US Real Estate Index Fd ETF trades at $45.69. The key difference: Revvity Inc pays a 0.26% dividend while Vanguard Global ex-US Real Estate Index Fd ETF pays none, and Revvity Inc is trading nearer its 52-week high, Vanguard Global ex-US Real Estate Index Fd ETF nearer its low. Which is the better fit depends on your goals.

RVTYVNQI
Market Cap
$11.87B
Sector
Technology
52-Week High
$117.75$50.76
52-Week Low
$82.26$43.26
Enterprise Value
$14.36B
Dividend Yield
0.26%

Returns comparison

Trailing returns across standard periods

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY

About Vanguard Global ex-US Real Estate Index Fd ETF

The fund employs an indexing investment approach designed to track the performance of the S&P Global ex-US Property Index, a float-adjusted, market-capitalization-weighted index that measures the equity market performance of international real estate stocks in both developed and emerging markets. The index is composed of stocks of publicly traded equity real estate investment trusts (known as REITs) and certain real estate management and development companies (REMDs).

Read more on VNQI